MedTrace Logo

Efficacy of ASIMOMMY® Compared to Domperidone and Placebo in Increasing Breastfeeding: Randomized Single-Blind Controlled Trial in Indonesia

NCT05596006 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2023-03-29

No results posted yet for this study

Summary

The purpose of this study is assess the efficacy of ASIMOMMY® in increasing breast milk production in postpartum mothers.

Conditions

  • Breastfeeding Mothers

Interventions

DRUG

ASIMOMMY®

ASIMOMMY 500 mg

DRUG

Domperidon

Domperidone capsule 10 mg

DRUG

Placebo

Capsules of placebo 500mg.

Sponsors & Collaborators

  • Gadjah Mada University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2023-03-24
Completion
2023-03-24

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05596006 on ClinicalTrials.gov